A Canadian in America: long-term outcomes of the Svensson modification of the David operation
Report on the very long-term outcomes (15 years) of a single-surgeon experience at the Cleveland Clinic with aortic root reimplantation surgery.
Valvulopathies
Transcarotid access for TAVR: sustained safety and efficacy at five years
Prospective observational study evaluating 5-year clinical outcomes of transcarotid TAVR in moderate-to-high surgical risk patients with no viable femoral access.
Evolution of mitral regurgitation after TAVI: functional improvement or marker of poor prognosis?
This retrospective observational study evaluated 2250 patients who underwent TAVI, comparing outcomes based on the presence or absence of significant (moderate or greater) concomitant mitral regurgitation (MR).
Stale bread and reheated leftovers: 4-year update of the evolut low risk trial
Commentary on a reanalysis of the 4-year results from the Evolut Low Risk trial, excluding Abbott/St. Jude Trifecta prostheses from the surgical cohort.
When to intervene in aortic regurgitation: practical recommendations according to the 2021 esc/eacts guidelines
This summary updates the indications for intervention in aortic regurgitation (AR) according to the 2021 ESC/EACTS guidelines, with a practical and clinically oriented perspective.
Repair or replace? critical decisions after failed Mitraclip®
The international multicenter CUTTING-EDGE registry investigates surgical strategies and outcomes in patients undergoing conventional surgery after failed mitral transcatheter edge-to-edge repair (M-TEER).
Ten-year outcomes of the Epic® porcine valve: is the Abbott® as good as it looks?
This retrospective observational study, based on real-world data, aimed to assess the 10-year outcomes of the St. Jude/Abbott Epic® porcine mitral valve.
Survival analysis in the presence of paravalvular leak after TAVI: size does matter
This was a single-center, retrospective observational cohort study that assessed the prevalence of paravalvular leak (PVL) following transcatheter aortic valve implantation (TAVI) in over 3000 patients and its impact on long-term survival based on leak severity.
When to intervene in aortic stenosis? current recommendations and what the future may hold.
We review the indications for intervention in aortic stenosis (AS) according to the 2021 ESC/EACTS Guidelines, offering a practical perspective on how to apply these recommendations in real-world surgical settings. Additionally, we analyze recent evidence that may anticipate significant updates in future guideline revisions.
Tenacity versus obstinacy: five-year echocardiographic results of the PARTNER 3 trial
Subanalysis of the hemodynamic performance by echocardiography of Edwards LifeSciences® surgical bioprostheses and TAVR devices in the PARTNER 3 trial with five-year follow-up